Despite emerging advances in the management of a patient with ischemic stroke at many tertiary care centers, administering tissue plasminogen activator (tPA) remains the first-line modality in most of the community hospitals where endovascular procedures might not be available at an appropriate time. Here, PLAT is linked to ischemic stroke.